Cargando…

Natural History of NAFLD/NASH

PURPOSE OF REVIEW: The purpose of this review is to summarize the latest knowledge on the natural history of non-alcoholic fatty liver disease (NAFLD). The review focuses on mortality, liver-related complications, and histological course. RECENT FINDINGS: Studies during the last decade have establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekstedt, Mattias, Nasr, Patrik, Kechagias, Stergios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Fatty Liver Disease (S Harrison and J George, Section Editors)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022523/ https://www.ncbi.nlm.nih.gov/pubmed/29984130 http://dx.doi.org/10.1007/s11901-017-0378-2

Ejemplares similares

Repeated measurements of non‐invasive fibrosis tests to monitor the progression of non‐alcoholic fatty liver disease: A long‐term follow‐up study
por: Balkhed, Wile, et al.
Publicado: (2022)

Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD
por: Blomdahl, Julia, et al.
Publicado: (2023)

Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
por: Holmer, Magnus, et al.
Publicado: (2022)

Natural history of nonalcoholic fatty liver disease: A prospective follow‐up study with serial biopsies
por: Nasr, Patrik, et al.
Publicado: (2017)

TASL Practice Guidance on the Clinical Assessment and Management of Patients with Nonalcoholic Fatty Liver Disease
por: Yilmaz, Yusuf, et al.
Publicado: (2023)

Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes
por: Carrieri, Patrizia, et al.
Publicado: (2022)

Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
por: Kechagias, Stergios, et al.
Publicado: (2022)

The synergistic effect of Citrus bergamia and Cynara cardunculus extracts on vascular inflammation and oxidative stress in non-alcoholic fatty liver disease
por: Musolino, Vincenzo, et al.
Publicado: (2020)

Beneficial effects of Chinese herbs in the treatment of fatty liver diseases
por: Panyod, Suraphan, et al.
Publicado: (2020)

Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study
por: Zhang, Xiaofang, et al.
Publicado: (2020)

Current treatment of non‐alcoholic fatty liver disease
por: Paternostro, Rafael, et al.
Publicado: (2022)

Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol
por: Nasr, Patrik, et al.
Publicado: (2021)

Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity
por: Di Mauro, Stefania, et al.
Publicado: (2019)

Infections in Cirrhosis
por: Ekpanyapong, Sirina, et al.
Publicado: (2019)

COVID-19 and Effect on Liver Transplant
por: Nobel, Yael R., et al.
Publicado: (2021)

Strategies to Improve Delivery of Cirrhosis Care
por: Moghe, Akshata, et al.
Publicado: (2021)

Symptom Management in Patients with Cirrhosis: a Practical Guide
por: Kaplan, Alyson, et al.
Publicado: (2022)

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017)

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study
por: Hagström, Hannes, et al.
Publicado: (2017)

Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH
por: Bruschi, Francesca V., et al.
Publicado: (2020)

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology
por: Calleja, José L., et al.
Publicado: (2022)

A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation
por: Houten, Sander Michel, et al.
Publicado: (2010)

The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results
por: Wanders, Ronald J. A., et al.
Publicado: (2010)

Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency
por: van Maldegem, Bianca T., et al.
Publicado: (2010)

Fatty acids and sleep in UK children: subjective and pilot objective sleep results from the DOLAB study – a randomized controlled trial
por: Montgomery, Paul, et al.
Publicado: (2014)

Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
por: Yacoub, A., et al.
Publicado: (2014)

The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia
por: Birgegård, Gunnar
Publicado: (2016)

Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
por: Bhatnagar, Neha, et al.
Publicado: (2016)

Sustainability of diet-based moderate calorie restriction among obese patients with metabolic-associated fatty liver disease
por: Guveli, Hakan, et al.
Publicado: (2021)

Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models
por: Jain, Mukul R., et al.
Publicado: (2017)

Serum aromatic and branched‐chain amino acids associated with NASH demonstrate divergent associations with serum lipids
por: de Mello, Vanessa D., et al.
Publicado: (2020)

PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH
por: Gastaldelli, Amalia, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
por: Shang, Ying, et al.
Publicado: (2020)

Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study
por: Björkström, Karl, et al.
Publicado: (2022)

Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2022)

Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto Experience
por: Barbas, Andrew S., et al.
Publicado: (2017)

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival
por: Villeret, François, et al.
Publicado: (2022)

Non-alcoholic fatty liver disease and diabetes
por: Hazlehurst, Jonathan M., et al.
Publicado: (2016)

NAFLD is related to Post‐prandial Triglyceride‐enrichment of HDL Particles in Association with Endothelial and HDL Dysfunction
por: Verwer, Bart J., et al.
Publicado: (2020)

Natural history of NASH
por: Armandi, Angelo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nnf0448afqm8d2sodufklddikr